HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.
HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.